UAMS approved for use of plasma as experimental treatment for COVID-19
LITTLE ROCK — The Food and Drug Administration has authorized the use of convalescent plasma in Arkansas as an experimental treatment for COVID-19 with the University of Arkansas for Medical Sciences (UAMS) as the expanded access treatment program sponsor.With the authorization, UAMS Medical Center... Read More.
